Navigation Links
ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results
Date:10/2/2009

IRVINE, Calif., Oct. 2 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will release third quarter 2009 financial results after market close on November 3, 2009. In conjunction, the Company will host a conference call at 5:00 p.m. Eastern Time to discuss these results and provide a pipeline update.

Date: Tuesday, November 3, 2009

Time: 5:00 p.m. Eastern Time

Conference call access:

Internet: www.istavision.com

Domestic dial-in: 800-510-9691

International dial-in: 617-614-3453

Passcode: 62898415

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 52451599. This conference call also will be webcast live and archived on ISTA's website until December 3, 2009.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA's four marketed products plus its product candidates include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.

SOURCE ISTA Pharmaceuticals, Inc.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
2. Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
3. Intercept Pharmaceuticals FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease
4. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
5. Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
6. Fovea Pharmaceuticals to be Acquired by sanofi-aventis
7. Sagent Pharmaceuticals Launches Vinorelbine Injection, USP
8. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
9. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
10. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
11. Arena Pharmaceuticals to Host Conference Call and Webcast on Friday, September 18, 2009, to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaserin for Weight Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 2017 FinancialBuzz.com News Commentary ... due to the significant development and innovation in EP ... Research, the global electrophysiology market was worth $3.42 billion ... by 2022, with a GAGR of 13.4%. Electrophysiology is ... abnormal heartbeats or arrhythmia. The report indicates that in ...
(Date:3/22/2017)... EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, ... Canada , today announced two new real-world data analyses ... 65 th Annual Pacific Coast Reproductive Society (PCRS) Meeting ... 24 th .   The results being presented are ... 2009 to December 2015 containing data from 15 fertility clinics ...
(Date:3/22/2017)... March 22, 2017  Levine Cancer Institute today ... unit designed to address lung cancer diagnosis, treatment ... Carolinas. The mobile lung unit is the first-of-its-kind ... and treatment interventions through integrated mobile technology, traditional ... Financial barriers and a lack of public transportation ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... “A Respectful ... “A Respectful Response To Atheist Manifesto” is the creation of published author Richard ... Nancy, for sixty years. He holds graduate degrees from Kent State University and ...
(Date:3/22/2017)... ... March 22, 2017 , ... Cosmetic Town, an ... issue of its companion print magazine. The new magazine, scheduled for release in ... information provided by board-certified doctors from across the country. , According to the ...
(Date:3/22/2017)... ... March 22, 2017 , ... Old School Labs™, makers of the best-selling Vintage ... new Brand Ambassador. Theophane, who trained with Floyd Mayweather, made his professional debut in ... racked up an impressive number of wins in contests in Britain, Germany and the ...
(Date:3/22/2017)... ... March 22, 2017 , ... Influence Health, ... digital marketing solutions have enabled Children’s Hospital of The King’s Daughters (CHKD) to ... Recognizing the value of a digital marketing approach, the 206-bed pediatric teaching hospital ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Burke Medical ... to translate advances in basic neuroscience at the BMRI labs into new and ... to improve movement, vision, and cognition impaired by stroke, traumatic brain injury, cerebral ...
Breaking Medicine News(10 mins):